Alés-Martínez, JE; Balmaña, J; Sánchez-Rovira, P; Bofill, FJS; Sáenz, JAG; Pimentel, I; Morales, S; Fernández-Abad, M; Martínez, AL; Ferrer, N; Zamora, P; Bermejo, B; Diaz-Redondo, T; López-Ceballos, MH; Galán, M; Pérez-Escuredo, J; Calabuig, L; Sampayo, M; Pérez-Garcia, JM; Cortés, J; Llombart-Cussac, A – 2024 – 10.1016/j.breast.2024.103780
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study – BREAST
by prodriguez | Jan 1, 2024 | Publicaciones - B-22 | 0 comments